BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9005790)

  • 1. [A method of sequential (intravenous and oral) use of ofloxacin in the treatment of patients with infections of organs of the peritoneal cavity].
    Savitskaia KI; Lobakov AI; Savov AM; Chernen'kaia TV; Nasonov VN; Rusanova EV; Silkina TA
    Antibiot Khimioter; 1996; 41(9):60-7. PubMed ID: 9005790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Stepdown ofloxacin therapy in bronchopulmonary diseases].
    Nonikov VE; Lenkova NI; Makarova OV; Ritchik LA
    Antibiot Khimioter; 1996; 41(9):50-2. PubMed ID: 9005787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical trials of ofloxacin in sequential use (intravenous and oral) in patients with serious hospital infection].
    Iakovlev SV; Dvoretskiĭ LI; Shakhova TV; Kudinkina IP; Vorob'ev PA; Vlasenko NA; Prokhorenko TS; Eremina LV
    Antibiot Khimioter; 1996; 41(9):53-6. PubMed ID: 9005788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of ofloxacin in infections which do not readily respond to treatment].
    Zalaudek G
    Antibiot Khimioter; 1996; 41(9):11-2. PubMed ID: 9005779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.
    Todd PA; Faulds D
    Drugs; 1991 Nov; 42(5):825-76. PubMed ID: 1723377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levofloxacin in the treatment of urinary tract infections and prostatitis.
    Naber KG
    J Chemother; 2004 Apr; 16 Suppl 2():18-21. PubMed ID: 15255558
    [No Abstract]   [Full Text] [Related]  

  • 7. [Outlook and experience in using ofloxacin in urology].
    Derevianko II; Kotliarova GA; Siniukhin VN
    Antibiot Khimioter; 1996; 41(9):89-94. PubMed ID: 9005797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic osteitis--modern therapy].
    Vittver V; Ketterl' R
    Antibiot Khimioter; 1996; 41(9):57-9. PubMed ID: 9005789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ten-year experience with the use of ofloxacin in the treatment of wound infection].
    Blatun LA; Iakovlev VP; Svetukhin AM; Puchkova LS; Izotova GN
    Antibiot Khimioter; 1996; 41(9):73-6. PubMed ID: 9005792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral ofloxacin therapy of infections due to multiply-resistant bacteria.
    Scully BE; Clynes N; Neu HC
    Diagn Microbiol Infect Dis; 1991; 14(5):435-41. PubMed ID: 1797458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ten-year experience with the use of ofloxacin in reconstructive surgery].
    Bogomolova NS; Bol'shakov LV; Vinogradova LN; Sorokina VI; Oreshkina TD
    Antibiot Khimioter; 1996; 41(9):68-72. PubMed ID: 9005791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with levofloxacin in the treatment of pneumonia in ICU patients.
    Alvarez Lerma F;
    J Chemother; 2004 Apr; 16 Suppl 2():15-7. PubMed ID: 15255557
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative evaluation of the effectiveness of ofloxacin in comprehensive treatment of acute inflammatory diseases of the uterus and uterine appendages].
    Savel'eva GM; Evseev AA; Denisova EN
    Antibiot Khimioter; 1996; 41(9):81-3. PubMed ID: 9005794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Drugs Exp Clin Res; 1987; 13(9):555-61. PubMed ID: 3480796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An attempt to use ofloxacin in patients with mucoviscidosis].
    Chuchalin AG; Sokolov AS; Apul'tsina ID; GUgutsidze EN; Kuchkina NV; Samsonova MV
    Antibiot Khimioter; 1996; 41(9):43-6. PubMed ID: 9005785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora.
    Edlund C; Sjöstedt S; Nord CE
    Scand J Infect Dis; 1997; 29(4):383-6. PubMed ID: 9360254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies.
    Timmers GJ; Dijstelbloem Y; Simoons-Smit AM; van Winkelhoff AJ; Touw DJ; Vandenbroucke-Grauls CM; Huijgens PC
    Bone Marrow Transplant; 2004 Apr; 33(8):847-53. PubMed ID: 14755314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic potential of ofloxacin in hospital medicine. A French multicenter study].
    Carbon C; Delval C
    Pathol Biol (Paris); 1990 May; 38(5):397-400. PubMed ID: 2195449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety evaluation of a new formulation of intravenous ofloxacin.
    Stein GE
    Drugs; 1995; 49 Suppl 2():497-8. PubMed ID: 8549414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.